Latest updates for Boston Scientific
Fresh curated links around Boston Scientific are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Boston Scientific: From Hypergrowth To Durable Compounding
- Boston Scientific funnels $1.5B into MiRus, with option to buy TAVR system
- FDA issues most serious recall for certain pacemaker devices by Boston Scientific
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Boston Scientific funnels $1.5B into MiRus, with option to buy TAVR system
Acquisitive Boston Scientific is making deals again, with a major investment play into a private medtech with an option to snap up exclusive rights to its Transcatheter Aortic Valv...
FDA issues most serious recall for certain pacemaker devices by Boston Scientific
The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after ide...
Axonics
Axonics Anonymous (not verified) Sun, 04/05/2026 - 17:00 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...
BofA Cuts PT on Boston Scientific Corporation (BSX) Over Worries for Medtech
Axonics
Axonics Anonymous (not verified) Sat, 05/09/2026 - 08:22 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...
Boston Scientific Corporation (BSX): Billionaire Tom Steyer Is Loading Up on This Stock
BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit
NEW YORK, April 7, 2026 /PRNewswire/ --
BSX Deadline: BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit
NEW YORK, May 2, 2026 /PRNewswire/ --
Stock Market Today, May 27: Boston Scientific Plunges After Reiterating Underwhelming Full Year Growth Guidance
Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today, May 27, 2026.
Boston Scientific announces €75m R&D investment in Galway
The organisation has stated that the investment will strengthen Galway’s position as a global centre for cardiovascular innovation. Read more: Boston Scientific announces €75m R&a...
Medtronic to shutter Santa Rosa plant as it restructures cardiovascular unit
Medtronic will shutter its Santa Rosa facility that produces coronary stents and other heart-related products over the next two years as the device maker also looks to restructure...
Artivion nabs PMA clearance for aortic stent graft system, triggers Endospan buyout option
Artivion, an Atlanta-based medtech that focuses on cardiac and vascular surgery, received pre-market approval (PMA) for its aortic stent graft system.
Abstract No. LBA22 Transforming Interventional Procedures with a New Category of Sensorized Smart Instruments
To evaluate novel sensorized ‘smart’ instruments that generate real-time imaging, localization, temperature, and pressure data directly at the instrument tip, enabling visualizatio...
Olympus pushes deeper into oncology with $270M BioProtect deal
Olympus is pushing deeper into prostate cancer care with the acquisition of BioProtect, an Israeli company whose biodegradable balloon spacer has been used in more than 11,000 proc...
Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe
Johnson & Johnson announced the launch of VARIPULSE Pro in Europe following CE Mark approval, further advancing its pulsed field ablation (PFA) portfolio. This new pulse sequen...
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal Puncture Device received 510(k) cle...
First Bellwether Trial Opens Against Bard Over Implanted Port Catheters
U.S. District Judge David Campbell of the District of Arizona is overseeing the trial, which began on April 21 and is set to wrap up by May 8.
C.R. Bard Wins Defense Verdict in First Bellwether Trial Over PowerPort Device
The trial, which began on April 21, is the first of about 3,000 cases in multidistrict litigation alleging Bard's PowerPort devices are defective, leading to blood infections, thro...
Abbott Vascular Clonmel
Abbott Vascular Clonmel Anonymous (not verified) Sun, 04/19/2026 - 08:10 field_thread_url https://cafepharma.com/boards/threads/abbott-vascular-clonmel.536...
J&J launches latest version of its pulsed ablation device after nabbing CE Mark
J&J Medtech launched the latest version of its pulsed ablation device after receiving CE Mark approval in Europe.
Abstract No. LBA20 Results from the GPX IDE Pivotal Clinical Trial (Evaluation of a Simple-Prep Controlled Embolic)
Distal embolization is desired for many embolic applications. In an IDE pivotal trial, a novel liquid embolic was used in both durable and pre-operative distal embolization procedu...
AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform
Acquisition extends AP Technologies' vertically integrated catheter platform into nitinol and precision laser processing. Dundalk, Ireland joins the company's network of Centers of...
Bioretec Advances U.S. Commercialization of First-of-Its-Kind Absorbable Metal Implant
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.